These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26110877)

  • 1. Overcoming inactivation of the lung surfactant by serum proteins: a potential role for fluorocarbons?
    Krafft MP
    Soft Matter; 2015 Aug; 11(30):5982-94. PubMed ID: 26110877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
    Zuo YY; Veldhuizen RA; Neumann AW; Petersen NO; Possmayer F
    Biochim Biophys Acta; 2008 Oct; 1778(10):1947-77. PubMed ID: 18433715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid lung profile in adult respiratory distress syndrome--evidence for surfactant abnormality.
    Pison U; Gono E; Joka T; Obertacke U
    Prog Clin Biol Res; 1987; 236A():517-23. PubMed ID: 3615448
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.
    Zasadzinski JA; Alig TF; Alonso C; Bernardino de la Serna J; Perez-Gil J; Taeusch HW
    Biophys J; 2005 Sep; 89(3):1621-9. PubMed ID: 16006630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous surfactant replacement in ARDS--one day, someday, or never?
    Baudouin SV
    N Engl J Med; 2004 Aug; 351(9):853-5. PubMed ID: 15329420
    [No Abstract]   [Full Text] [Related]  

  • 7. Alveolar environment influences the metabolic and biophysical properties of exogenous surfactants.
    Puligandla PS; Gill T; McCaig LA; Yao LJ; Veldhuizen RA; Possmayer F; Lewis JF
    J Appl Physiol (1985); 2000 Mar; 88(3):1061-71. PubMed ID: 10710404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant protein A (SP-A): the alveolus and beyond.
    Khubchandani KR; Snyder JM
    FASEB J; 2001 Jan; 15(1):59-69. PubMed ID: 11149893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surface activity of the surfactant in experimental compression atelectasis].
    Zagorul'ko AK; Birkun AA; Kobozev GV; Safronova LG
    Biull Eksp Biol Med; 1986 Sep; 102(9):277-9. PubMed ID: 3756324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of alveolar type II cells and intraalveolar surfactant after bronchoalveolar lavage and perfluorocarbon ventilation. An electron microscopical and stereological study in the rat lung.
    Rüdiger M; Wendt S; Köthe L; Burkhardt W; Wauer RR; Ochs M
    Respir Res; 2007 Jun; 8(1):40. PubMed ID: 17550584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.
    Zasadzinski JA; Stenger PC; Shieh I; Dhar P
    Biochim Biophys Acta; 2010 Apr; 1798(4):801-28. PubMed ID: 20026298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian inference of the lung alveolar spatial model for the identification of alveolar mechanics associated with acute respiratory distress syndrome.
    Christley S; Emr B; Ghosh A; Satalin J; Gatto L; Vodovotz Y; Nieman GF; An G
    Phys Biol; 2013 Jun; 10(3):036008. PubMed ID: 23598859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary surface-active factor (surfactant) in respiratory tract diseases].
    Puchkov GF; Iazvinskiĭ II
    Sov Med; 1975 Aug; (8):62-6. PubMed ID: 788185
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of exogenous surfactant by pulmonary edema fluid.
    Kobayashi T; Nitta K; Ganzuka M; Inui S; Grossmann G; Robertson B
    Pediatr Res; 1991 Apr; 29(4 Pt 1):353-6. PubMed ID: 1852528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sedimentation of surfactant in ventilated excised rat lungs. Physical alterations in surfactant associated with the development and reversal of atelectasis.
    Thet LA; Clerch L; Massaro GD; Massaro D
    J Clin Invest; 1979 Aug; 64(2):600-8. PubMed ID: 379047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-atelectasis factor of the lung. II].
    Winsel K; Lachmann B; Reutgen H
    Z Erkr Atmungsorgane Folia Bronchol; 1973-1974; 139(2):167-97. PubMed ID: 4603338
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling.
    Olmeda B; Martínez-Calle M; Pérez-Gil J
    Ann Anat; 2017 Jan; 209():78-92. PubMed ID: 27773772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.
    Autilio C; Pérez-Gil J
    Arch Dis Child Fetal Neonatal Ed; 2019 Jul; 104(4):F443-F451. PubMed ID: 30552091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.